Volume 55, Issue 2, Pages (February 1999)

Slides:



Advertisements
Similar presentations
Volume 65, Issue 1, Pages (January 2004)
Advertisements

Lymphatic vessels develop during tubulointerstitial fibrosis
Volume 65, Issue 1, Pages (January 2004)
Cell Physiol Biochem 2016;40: DOI: /
Volume 65, Issue 2, Pages (February 2004)
Osteopontin expression in human crescentic glomerulonephritis
Volume 56, Issue 4, Pages (October 1999)
Volume 54, Issue 1, Pages (July 1998)
Volume 55, Issue 2, Pages (February 1999)
Volume 74, Issue 10, Pages (November 2008)
Volume 57, Issue 4, Pages (April 2000)
Noninhibitory PAI-1 enhances plasmin-mediated matrix degradation both in vitro and in experimental nephritis  Y. Huang, W.A. Border, D.A. Lawrence, N.A.
Volume 68, Issue 3, Pages (September 2005)
Volume 68, Issue 6, Pages (December 2005)
Volume 65, Issue 1, Pages (January 2004)
Volume 60, Issue 2, Pages (August 2001)
Volume 70, Issue 7, Pages (October 2006)
Hyun Soon Lee, Young Sook Kim  Kidney International 
Volume 55, Issue 5, Pages (May 1999)
Volume 81, Issue 3, Pages (February 2012)
Volume 58, Issue 6, Pages (December 2000)
Volume 63, Issue 4, Pages (April 2003)
TGF-β isoforms in renal fibrogenesis
Volume 56, Issue 3, Pages (September 1999)
Volume 59, Issue 5, Pages (May 2001)
Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways  Youhua Liu, Krupa Rajur, Evelyn Tolbert,
Volume 55, Issue 4, Pages (April 1999)
Volume 55, Issue 2, Pages (February 1999)
Xue-Hui Liu, Achim Aigner, Anton Wellstein, Patricio E. Ray 
Volume 57, Issue 2, Pages (October 2000)
Volume 64, Pages S39-S45 (October 2003)
Volume 57, Issue 1, Pages (January 2000)
Volume 63, Issue 2, Pages (February 2003)
Volume 55, Issue 2, Pages (February 1999)
Volume 81, Issue 3, Pages (February 2012)
Lymphatic vessels develop during tubulointerstitial fibrosis
Volume 57, Issue 3, Pages (March 2000)
Volume 57, Issue 1, Pages (January 2000)
Xue-Hui Liu, Achim Aigner, Anton Wellstein, Patricio E. Ray 
Volume 61, Issue 6, Pages (June 2002)
Izabella Z.A. Pawluczyk, Kevin P.G. Harris  Kidney International 
Blockade of NFκB activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney  Yee-Yung Ng, Chun-Cheng Hou, Wansheng.
Volume 66, Issue 5, Pages (November 2004)
HIV-related nephropathy: A South African perspective
Expression of connective tissue growth factor in human renal fibrosis
Effect of nitric oxide modulation on TGF-β1 and matrix proteins in chronic cyclosporine nephrotoxicity  Fuad S. Shihab, Hong Yi, William M. Bennett, Takeshi.
C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis  Gopala K. Rangan, Jeffrey W. Pippin, William.
Volume 54, Issue 4, Pages (October 1998)
Volume 59, Issue 4, Pages (April 2001)
Volume 56, Issue 5, Pages (November 1999)
Jens Gaedeke, Nancy A. Noble, Wayne A. Border  Kidney International 
Volume 61, Issue 1, Pages (January 2002)
Volume 55, Issue 6, Pages (June 1999)
Volume 69, Issue 11, Pages (June 2006)
Volume 60, Issue 5, Pages (November 2001)
Volume 65, Issue 6, Pages (June 2004)
Volume 57, Issue 5, Pages (May 2000)
Volume 58, Issue 3, Pages (September 2000)
Volume 58, Issue 5, Pages (November 2000)
Volume 58, Issue 4, Pages (October 2000)
Sequential effects of high glucose on mesangial cell transforming growth factor-β1 and fibronectin synthesis  Jong Hoon Oh, Hunjoo Ha, Mi Ra Yu, Hi Bahl.
Naoki Ikegaya, Akira Hishida, Tatsuo Yamamoto  Kidney International 
Volume 73, Issue 5, Pages (March 2008)
Jens Gaedeke, Nancy A. Noble, Wayne A. Border  Kidney International 
T-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis  Masashi Haraguchi, Wayne A. Border, Yufeng Huang,
The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?  Richard E. Gilbert, Mark E. Cooper  Kidney.
Volume 65, Issue 1, Pages (January 2004)
Volume 70, Issue 1, Pages (July 2006)
Volume 56, Issue 4, Pages (October 1999)
Volume 57, Issue 1, Pages (January 2000)
Presentation transcript:

Volume 55, Issue 2, Pages 579-592 (February 1999) Increased levels of transforming growth factor-β in HIV-associated nephropathy  Tatsuo Yamamoto, Nancy A. Noble, Diane E. Miller, Leslie I. Gold, Akira Hishida, Mitsumasa Nagase, Arthur H. Cohen, Wayne A. Border  Kidney International  Volume 55, Issue 2, Pages 579-592 (February 1999) DOI: 10.1046/j.1523-1755.1999.00296.x Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 1 Immunofluorescence micrographs of TGF-β1 (a, d), TGF-β2 (b, e), and TGF-β3 (c, f) in serial sections of HIVAN (a–c) and normal control (d–f). In HIVAN, strong staining of the three TGF-β isoforms was observed in the sclerosing glomeruli, parietal epithelial cells, and the periglomerular and tubulointerstitial lesions with interstitial mononuclear cell infiltration and matrix deposition (magnification ×210). Kidney International 1999 55, 579-592DOI: (10.1046/j.1523-1755.1999.00296.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 2 Glomerular (A) and tubulointerstitial (b) immunofluorescence staining scores of TGF-β1 (▪), TGF-β2 (▨), and TGF-β3 () in HIV-negative, normal control (NC), thin basement membrane disease (TBMD), minimal change disease (MC), focal and segmental glomerulosclerosis (FSG), and immune complex glomerulonephritis in HIV-infected patients (ICGN, HIV+) and HIV-associated nephropathy (HIVAN). The error bars represent se. *P < 0.01 versus NC, TBMD, and MC; P < 0.05 versus FGS. Kidney International 1999 55, 579-592DOI: (10.1046/j.1523-1755.1999.00296.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 3 In situ hybridization demonstrating the expression of TGF-β1 mRNA (a, d, g, j), TGF-β2 mRNA (b, e, h, k), and TGF-β3 mRNA (c, f, i, l) in serial sections of HIVAN (a–f) and in HIV-negative focal and segmental glomerulosclerosis (g–i) and normal control (j–l). Increased expression of TGF-β mRNA of all three isoforms was observed in the glomeruli and tubulointerstitium of HIVAN (a–c) and focal and segmental glomerulosclerosis (g–i). However, the intensity of mRNA expression for the three TGF-β isoforms was much greater in HIVAN. A large number of interstitial infiltrative mononuclear cells were also strongly expressing the three TGF-β isoforms’ mRNAs in HIVAN (d–f; magnification of a–c and g–l ×135 and d–f = ×100). Kidney International 1999 55, 579-592DOI: (10.1046/j.1523-1755.1999.00296.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 4 Immunofluorescence micrographs of fibronectin EDA+ (a, c) and PAI-1 (b, d) in serial sections of HIVAN (a, b) and normal control (c, d). Remarkably strong intraglomerular and tubulointerstitial staining of fibronectin EDA+ and PAI-1 was observed in HIVAN (magnification ×230). Kidney International 1999 55, 579-592DOI: (10.1046/j.1523-1755.1999.00296.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 5 Glomerular (A) and tubulointerstitial (b) immunofluorescence staining scores of fibronectin EDA+ (▪) and PAI-1 (▨) in HIV-negative, normal control (NC), thin basement membrane disease (TBMD), minimal change disease (MC), focal and segmental glomerulosclerosis (FGS), and immune complex glomerulopathy in HIV-infected patients (ICGN, HIV+) and HIV-associated nephropathy (HIVAN). The error bars represent se. *P < 0.01 versus NC, TBMD, and MC; P < 0.01 vs. FGS and #P < 0.05 versus ICGN, HIV + 0. Kidney International 1999 55, 579-592DOI: (10.1046/j.1523-1755.1999.00296.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 6 Tat-staining of HIVAN (a), HIV-positive membranous nephropathy (b), histologically normal kidney obtained from a patient infected with HIV (c), and HIV-negative focal and segmental glomerulosclerosis (d), membranous nephropathy (e), and minimal change disease (f). Remarkably strong staining of Tat was noted in the glomerular, tubular, and infiltrative interstitial mononuclear cells in HIVAN (a). No tubular casts were stained positively. In HIV-positive membranous nephropathy (b) and a histologically normal kidney obtained from a HIV-infected patient (c), the tubules were weakly stained. No Tat staining was found in the glomeruli or interstitial mononuclear cells in HIV-negative primary glomerular diseases (d, e, f); however, some tubules were stained faintly (magnification ×240). Kidney International 1999 55, 579-592DOI: (10.1046/j.1523-1755.1999.00296.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 7 Northern blot data showing the expression of TGF-β1 (A), type I collagen (B), biglycan (C), and GAPDH (D) mRNAs in human mesangial cells incubated for 48hours with 0 (lane 1), 25 (lane 2), 100 (lane 3), and 500ng/ml (lane 4) of Tat protein. Graphical presentation of densitometric analysis of gels shown in A–C corrected for GAPDH shown in D. (E) A stepwise increase in expression of TGF-β1 (□), type I collagen (▪), and biglycan (▧) mRNAs was noted in human mesangial cells stimulated by Tat protein. Kidney International 1999 55, 579-592DOI: (10.1046/j.1523-1755.1999.00296.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 8 Levels of activated total TGF-β1, measured by ELISA, in supernatants from human mesangial cell cultures exposed for 48hours to increasing concentrations of recombinant Tat protein. A significant correlation was seen between Tat added and TGF-β1 released into culture supernatants (P < 0.01. r2 = 0.787). Kidney International 1999 55, 579-592DOI: (10.1046/j.1523-1755.1999.00296.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Kidney International 1999 55, 579-592DOI: (10. 1046/j. 1523-1755. 1999 Kidney International 1999 55, 579-592DOI: (10.1046/j.1523-1755.1999.00296.x) Copyright © 1999 International Society of Nephrology Terms and Conditions